The U.S. Food and Drug Administration granted premarket notification clearance for two catheters originally developed by Riyaz Bashir, MD, FACC, Professor of Medicine at the Lewis Katz School of Medicine at Temple University and Director of Vascular and Endovascular Medicine at Temple University Hospital; and Nicholas Green, Director of Research and Development at Thrombolex, Inc. The announcement received coverage from Endovascular Today, Scienmag and Bioengineer.org.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH